Home » Program Overview » Overview of Training Tracks » TRACK I: TRANSFUSION MEDICINE & HEMOGLOBINOPATHIES

TRACK I: TRANSFUSION MEDICINE & HEMOGLOBINOPATHIES

Transfusion Medicine and Hemoglobinopathies represent a significant component of the T32 training program.  Research in this track involves both basic and clinical research programs. Basic/translational programs in this track encompass biochemistry and genetics of blood cell antigens, (Telen), mechanisms of immune destruction of blood cells by allo-and autoantibodies (Telen, Arepally); transfusion for hemoglobinopathies (Telen, Strouse & Shah); mechanisms of red cell phospholipid exposure (Yang, Telen), oxidative damage (Zennadi), storage and nitric oxide generation (McMahon) focuses on sickle cell disease therapeutics (Telen & Shah);  environmental triggers for sickle cell disease (Strouse), aging in sickle cell disease (Telen & Strouse); mobile tools for monitoring sickle cell pain (Shah); malaria chemoprevention in sickle cell cell disease (Taylor) and blood separation technologies (Huang)..

Track I Faculty: Transfusion Medicine & Hemoglobinopathies
Jen-Tsan Ashley Chi (Red cell genomics) Jennifer Rothman, MD
Tony Huang, PhD (Acoustofluidic blood separation) Steve Taylor, MD, MHS (Sickle Cell & Malaria)
Allison Ashely-Koch, PhD (Genomics of Sickle cell disease) Nirmish Shah, MD
(Sickle cell/mobile health)
Grace Lee MD (Neutrophils, Sickle Cell)Grace Lee MD (Transfusion Medicine, Apheresis)
Timothy McMahon, MD, PhD (RBC storage/nitric oxide) JJ Strouse, MD, PhD
(Sickle cell environment & aging)
Marilyn J Telen MD (Sickle RBC biology & alloimmunization) Marilyn J Telen,MD (Sickle cell new therapeutics)
Huanghe Yang, PhD (RBC membrane phospholipid) Ian Welsby, MD (perioperative transfusions in surgery)
Adjunct Faculty
Basic/Translational Research Faculty Clinical Research Research Faculty
Nicholas Bandarenko, MD (Medical Director of Transfusion Medicine); Toyosi Onwuemene, MD (Therapeutic Apheresis), and Regina Crawford, MD (hemolytic transfusion reactions)

 

Educational Resources for Track I Trainees

Conferences and Seminars available to Track I participants
Conference Conference Description Attendees and Interactions
Interdisciplinary Hematology Conference This interdisciplinary conference covers case-based discussions as well as quarterly basic scientific research seminars. Held weekly, Tuesday AM MDs, PhDs in adult and pediatric hematology, transfusion medicine, pathology and biochemistry.
Transfusion Medicine Rounds Clinical rounding conference held in Transfusion Medicine four times a week for one hour. Transfusion Medicine Faculty, clinical fellows and residents.
Sickle Cell Research Program This is a monthly seminar to discuss clinical/translational and basic research activities of the Duke Adult and Pediatric Sickle Cell Programs. MDs, PhDs, research personnel, grad students studying sickle cell disease, other interested investigators
Immunology Research Seminars Invited speaker series to review major research developments in immunology. Held weekly, Tuesday 11 AM PhDs, MDs, post-doctorate fellows and graduate students
Biochemistry Seminars Invited speaker series of nationally and internationally recognized researchers. Held weekly, Fridays at Noon. Biochemistry faculty, graduate students and post-doctorate fellows

 

Graduate courses available to Track I Trainees

Trainees in Track I are encouraged to pursue additional graduate level classes in biochemistry and immunology to supplement their basic and/or clinical research.

For trainees involved in basic research, suggested coursework include: introductory class Principles of Immunology (IMM244,) Contemporary Topics in Membrane Biology (Biochem 631), Immunology (IMM291), Immunopathogenesis (IMM210), Structural Biochemistry I/II (IMM/BIOCHEM 258/259), Biophysical Methods (BIOCHEM 681) and Molecular Aspects of Disease (PTH385).

For trainees involved in clinical research, in addition to introductory courses in statistics (CRP241& 245) and principles of clinical research (CRP242), they would take Proteomics and Protein Biology in Medicine (CRP 257) and Patient-reported Outcomes in Medicine (CRP 271).